American pharmaceutical giant Regeneron will create more than 400 new jobs at its Limerick facility, bringing the total number of people employed at the campus to more than 1,400. The expansion is ...

Regeneron has been in Limerick since 2014, when it took over the old Dell factory in the city and has since invested over $1 billion in its campus which became operational in 2015.

Executive vice president and general manager of IOPS, Dan Van Plew at Regeneron said: “As this pandemic hit, we needed to quickly change how we do things and where we make our products. In order ...

Regeneron has said that to enable its US manufacturing site to produce large-scale quantities of REGN-COV2, they have licensed some additional products to be manufactured at their Limerick facility.

Regeneron Pharmaceuticals is to create 400 jobs in Limerick. This brings to 1,400 the total number of people employed by the group in Ireland.

Limerick, Ireland (October 19, 2015) -- Regeneron Pharmaceuticals, Inc., (NASDAQ: REGN) a leading science-driven biopharmaceutical company, today announced that it is investing an additional $350 ...

Regeneron Pharmaceuticals, which employs 300 people at its international production site in Limerick, is expanding its workforce by a further 200 people. The people already employed at the Raheen ...

The € 350m investment in its Limerick industrial operations and product supply (IOPS) bioprocessing campus will bring the total number of jobs at Regeneron to 500 jobs by the end of 2017.

US biopharma company Regeneron Pharmaceuticals is to create 300 new jobs in Ireland as part of a new $100 million investment. The company has announced a further expansion of its Limerick ...

A North American pharmaceutical company has sought permission to establish a $300m (€217.8m, £184.2m) production facility in Limerick with the potential to bring 900 jobs to the region. If the plans ...

Regeneron Pharmaceuticals is to invest $300 million and create 300 high-skill jobs at the former Dell site in Limerick by 2016. The investment by the American firm, which is subject to planning ...